IRELAND – Medical technology company Stryker has launched its new Gamma4 System, a precision nailing device for treating stable and unstable fractures and stabilizing bones.
Gamma4 includes a precision pin that reduces skiving by 66 percent, a redefined nail design, and an integrated platform that allows all of Stryker’s nails to work off of the existing basic set.
With the newest Gamma System, surgeons will get access to the company’s next-generation intramedullary nailing system, which has also been designed to stabilize bones.
The Gamma4 System is also indicated to correct bone deformities in the intracapsular, subtrochanteric, trochanteric, and shaft regions of the femur.
Gamma4 treats stable and unstable fractures as well as stabilizes bones and corrects bone deformities in the intracapsular, trochanteric, subtrochanteric, and shaft regions of the femur, which include osteoporotic and osteopenic bone.
About 90% of hip fractures are linked to falls, which are more common in older people, who tend to be frailer and have weaker bones.
But fractures can often drive further frailty, which increases the risk of more falls and worse frailty.
“Since 2004, the Gamma3 System has been the proven workhorse of our Trauma business,” said Eric Tamweber, Vice president and General Manager, Stryker’s Trauma business unit.
“But we aren’t proven because we have a legacy; we have a legacy because we are proven. That’s why we’re so excited to introduce Gamma4 — an enhanced, modern product that is designed to fulfill our customers’ hip fracture needs.”
The Gamma4 System is also indicated to correct bone deformities in the intracapsular, subtrochanteric, trochanteric, and shaft regions of the femur.
Dr. James Maxey, an orthopedic surgeon, worked as a design surgeon for Gamma4. He said the designers aimed to “make it easier” for surgeons and better for patients.
In September last year, Stryker introduced the Citrelock Tendon Fixation Device System. The system was designed to enable fixation without causing damage to the tendon during placement.
Citrelock Tendon Fixation Device System offers a controlled and homogeneous resorption process while preventing bulk degradation and chronic inflammation
It also offers surgeons a strength similar to cortical bone and a modulus in line with cancellous bone.
In other news, Stryker recently celebrated the official opening of its high-tech facility in Anngrove, Ireland.
The new 156,000-square-foot facility is focused on furthering the company’s development of additive manufacturing technology for healthcare applications.
Stryker said it has made significant investments in Anngrove to establish itself as a world leader in this technology and will continue to invest for growth.
Stryker applies additive manufacturing, also known as 3D printing, to an array of healthcare innovations, with a special emphasis on the manufacture of specialized medical devices.
Stryker is ranked as the ninth largest medical device company in the world by revenue, according to MD+DI.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
